Published in Cardiovasc Res on July 01, 2004
Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein S-nitrosylation and tyrosine nitration. J Immunol (2008) 1.13
Andrographolide enhances nuclear factor-kappaB subunit p65 Ser536 dephosphorylation through activation of protein phosphatase 2A in vascular smooth muscle cells. J Biol Chem (2010) 1.03
Amadori adducts activate nuclear factor-kappaB-related proinflammatory genes in cultured human peritoneal mesothelial cells. Br J Pharmacol (2005) 0.98
Implications of glial nitric oxide in neurodegenerative diseases. Front Cell Neurosci (2015) 0.93
Impaired hepatic insulin signalling in PON2-deficient mice: a novel role for the PON2/apoE axis on the macrophage inflammatory response. Biochem J (2011) 0.88
The timing of TNF and IFN-gamma signaling affects macrophage activation strategies during Mycobacterium tuberculosis infection. J Theor Biol (2008) 0.82
Nitric oxide synthases, S-nitrosylation and cardiovascular health: from molecular mechanisms to therapeutic opportunities (review). Mol Med Rep (2014) 0.81
Novel strategies for the treatment of inflammatory hyperalgesia. Eur J Clin Pharmacol (2010) 0.81
The multi-faceted behavior of nitric oxide in vascular "inflammation": catchy terminology or true phenomenon? Cardiovasc Res (2004) 0.79
S-nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma. Redox Biol (2015) 0.79
A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages. J Inflamm (Lond) (2008) 0.79
Andrographolide inhibits nuclear factor-κB activation through JNK-Akt-p65 signaling cascade in tumor necrosis factor-α-stimulated vascular smooth muscle cells. ScientificWorldJournal (2014) 0.78
Hormetic signaling patterns. Dose Response (2011) 0.78
Does peroxynitrite sustain nuclear factor-kappaB? Cardiovasc Res (2005) 0.78
The effects of reactive species on the tumorigenic phenotype of human head and neck squamous cell carcinoma (HNSCC) cells. Anticancer Res (2008) 0.77
Serum estradiol levels predict survival and acute kidney injury in patients with septic shock--a prospective study. PLoS One (2014) 0.77
Vasodilator-stimulated phosphoprotein protects against vascular inflammation and insulin resistance. Am J Physiol Endocrinol Metab (2014) 0.77
NOSH-NBP, a Novel Nitric Oxide and Hydrogen Sulfide- Releasing Hybrid, Attenuates Ischemic Stroke-Induced Neuroinflammatory Injury by Modulating Microglia Polarization. Front Cell Neurosci (2017) 0.76
PMC, a potent hydrophilic α-tocopherol derivative, inhibits NF-κB activation via PP2A but not IκBα-dependent signals in vascular smooth muscle cells. J Cell Mol Med (2014) 0.76
SNOSID, a proteomic method for identification of cysteine S-nitrosylation sites in complex protein mixtures. Proc Natl Acad Sci U S A (2006) 2.89
Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension (2006) 2.42
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nat Chem Biol (2011) 2.42
Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models. Proc Natl Acad Sci U S A (2009) 2.35
Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS. Am J Physiol Heart Circ Physiol (2008) 1.75
Globular adiponectin activates nuclear factor-kappaB and activating protein-1 and enhances angiotensin II-induced proliferation in cardiac fibroblasts. Diabetes (2007) 1.68
Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen. Circ Res (2003) 1.44
Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. J Am Soc Nephrol (2004) 1.29
Unbiased identification of cysteine S-nitrosylation sites on proteins. Nat Protoc (2007) 1.20
Balancing reactivity against selectivity: the evolution of protein S-nitrosylation as an effector of cell signaling by nitric oxide. Cardiovasc Res (2007) 1.20
Disabling a C-terminal autoinhibitory control element in endothelial nitric-oxide synthase by phosphorylation provides a molecular explanation for activation of vascular NO synthesis by diverse physiological stimuli. J Biol Chem (2002) 1.16
HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells. Arterioscler Thromb Vasc Biol (2003) 1.14
Argininosuccinate synthetase is reversibly inactivated by S-nitrosylation in vitro and in vivo. J Biol Chem (2004) 1.13
Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res (2003) 1.13
Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hypertension (2002) 1.12
Haplotype analysis reveals founder effects of thyroglobulin gene mutations C1058R and C1977S in Japan. J Clin Endocrinol Metab (2006) 1.12
Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ Res (2002) 1.11
Pioglitazone treatment of insulin resistance in a patient with Werner's syndrome. Diabetes Care (2004) 1.05
Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer. Breast Cancer Res (2015) 1.04
Untargeted plasma metabolite profiling reveals the broad systemic consequences of xanthine oxidoreductase inactivation in mice. PLoS One (2012) 1.03
Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice. Arterioscler Thromb Vasc Biol (2007) 1.01
Adiponectin induces NF-kappaB activation that leads to suppression of cytokine-induced NF-kappaB activation in vascular endothelial cells: globular adiponectin vs. high molecular weight adiponectin. Diab Vasc Dis Res (2008) 0.99
Retracted Hypoadiponectinemia is caused by chronic blockade of nitric oxide synthesis in rats. Metabolism (2005) 0.99
The mechanism of potent GTP cyclohydrolase I inhibition by 2,4-diamino-6-hydroxypyrimidine: requirement of the GTP cyclohydrolase I feedback regulatory protein. J Biol Chem (2004) 0.98
Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation. Eur J Pharmacol (2003) 0.98
Electrospray tandem mass spectrometry analysis of S- and N-nitrosopeptides: facile loss of NO and radical-induced fragmentation. J Am Soc Mass Spectrom (2006) 0.97
Retracted Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Cardiovasc Res (2008) 0.95
Unbiased metabolite profiling indicates that a diminished thymidine pool is the underlying mechanism of colon cancer chemoprevention by alpha-difluoromethylornithine. Cancer Discov (2013) 0.95
Protein 3-nitrotyrosine in complex biological samples: quantification by high-pressure liquid chromatography/electrochemical detection and emergence of proteomic approaches for unbiased identification of modification sites. Methods Enzymol (2008) 0.95
Heme catalyzes tyrosine 385 nitration and inactivation of prostaglandin H2 synthase-1 by peroxynitrite. J Lipid Res (2006) 0.95
Natriuretic peptide/natriuretic peptide receptor-A (NPR-A) system has inhibitory effects in renal fibrosis in mice. Regul Pept (2009) 0.94
Profound biopterin oxidation and protein tyrosine nitration in tissues of ApoE-null mice on an atherogenic diet: contribution of inducible nitric oxide synthase. Am J Physiol Heart Circ Physiol (2007) 0.94
Globular adiponectin induces adhesion molecule expression through the sphingosine kinase pathway in vascular endothelial cells. Life Sci (2007) 0.93
KCNQ1, KCNE2, and Na+-coupled solute transporters form reciprocally regulating complexes that affect neuronal excitability. Sci Signal (2014) 0.93
Ventricular fibrillation due to severe hypokalemia induced by steroid treatment in a patient with thyrotoxic periodic paralysis. Intern Med (2006) 0.93
Activation of AMP-activated protein kinase enhances angiotensin ii-induced proliferation in cardiac fibroblasts. Hypertension (2005) 0.91
Fenofibrate suppresses microvascular inflammation and apoptosis through adenosine monophosphate-activated protein kinase activation. Metabolism (2010) 0.91
Telmisartan inhibits cytokine-induced nuclear factor-kappaB activation independently of the peroxisome proliferator-activated receptor-gamma. Hypertens Res (2009) 0.91
Globular adiponectin activates nuclear factor-kappaB in vascular endothelial cells, which in turn induces expression of proinflammatory and adhesion molecule genes. Diabetes Care (2006) 0.90
Renal hemodynamic and ureteral pressure changes in response to ureteral obstruction: the role of nitric oxide. J Urol (2003) 0.90
The scavenger receptor CD36 contributes to the neurotoxicity of bone marrow-derived monocytes through peroxynitrite production. Neurobiol Dis (2011) 0.89
S-sulfhydration/desulfhydration and S-nitrosylation/denitrosylation: a common paradigm for gasotransmitter signaling by H2S and NO. Methods (2013) 0.89
Neutral loss of isocyanic acid in peptide CID spectra: a novel diagnostic marker for mass spectrometric identification of protein citrullination. J Am Soc Mass Spectrom (2008) 0.88
Protein nitrotryptophan: formation, significance and identification. J Proteomics (2011) 0.88
Tetrahydrobiopterin prevents endothelial dysfunction and restores adiponectin levels in rats. Eur J Pharmacol (2006) 0.87
Urinary proteomic analysis of chronic allograft nephropathy. Proteomics Clin Appl (2008) 0.86
Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells. Int J Cardiol (2010) 0.86
Inducible nitric oxide synthase mediates prostaglandin h2 synthase nitration and suppresses eicosanoid production. Am J Pathol (2006) 0.86
The N-terminal peptide of mammalian GTP cyclohydrolase I is an autoinhibitory control element and contributes to binding the allosteric regulatory protein GFRP. J Biol Chem (2010) 0.85
Inducible nitric oxide synthase promotes pathophysiological consequences of experimental bladder outlet obstruction. J Urol (2003) 0.85
Beyond tissueInfo: functional prediction using tissue expression profile similarity searches. Nucleic Acids Res (2008) 0.85
Herbal medicine, Hachimi-jio-gan, and its component cinnamomi cortex activate the peroxisome proliferator-activated receptor alpha in renal cells. Endocr J (2008) 0.85
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study. Eur Heart J (2007) 0.85
Induction of gene expression in response to globular adiponectin in vascular endothelial cells. Life Sci (2009) 0.84
Case of Werner's syndrome with pancreatic carcinoma. J Dermatol (2007) 0.83
Application of combined omics platforms to accelerate biomedical discovery in diabesity. Ann N Y Acad Sci (2013) 0.83
[Plaque score in the diagnosis of arteriosclerosis]. Nihon Rinsho (2004) 0.82
Circulating concentrations of soluble leptin receptor: influence of menstrual cycle and diet therapy. Nutrition (2002) 0.82
Anti-inflammatory role of cilostazol in vascular smooth muscle cells in vitro and in vivo. J Atheroscler Thromb (2010) 0.82
Effects of twice-daily injections of premixed insulin analog on glycemic control in type 2 diabetic patients. Yonsei Med J (2010) 0.82
Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: fluvastatin vs. rosuvastatin. Int J Cardiol (2009) 0.81
Characterization of a cellular denitrase activity that reverses nitration of cyclooxygenase. Am J Physiol Heart Circ Physiol (2013) 0.81
A novel splice variant of the nuclear coactivator p120 functions strongly for androgen receptor: characteristic expression in prostate disease. Endocr J (2008) 0.80
Anxiety-associated alternative polyadenylation of the serotonin transporter mRNA confers translational regulation by hnRNPK. Proc Natl Acad Sci U S A (2013) 0.80
Glutamine supplementation alleviates vasculopathy and corrects metabolic profile in an in vivo model of endothelial cell dysfunction. PLoS One (2013) 0.80
Maintaining equilibrium by selective targeting of cyclooxygenase pathways: promising offensives against vascular injury. Hypertension (2007) 0.80
Physical evidence for substrate binding in preventing cyclooxygenase inactivation under nitrative stress. J Am Chem Soc (2010) 0.80
Activation and inactivation of neuronal nitric oxide synthase: characterization of Ca(2+)-dependent [125I]Calmodulin binding. Eur J Pharmacol (2002) 0.80
Technology Insight: renal proteomics--at the crossroads between promise and problems. Nat Clin Pract Nephrol (2006) 0.79
Retracted Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells. Cardiovasc Res (2002) 0.79
Untargeted metabolite profiling of murine embryos to reveal metabolic perturbations associated with neural tube closure defects. Birth Defects Res A Clin Mol Teratol (2014) 0.79
Elevated plasma adiponectin and leptin levels in sisters with genetically defective insulin receptors. Diabetes Care (2007) 0.78
Retracted Disruption of the actin cytoskeleton up-regulates iNOS expression in vascular smooth muscle cells. J Cardiovasc Pharmacol (2004) 0.78
Effects of changeover from voglibose to acarbose on postprandial triglycerides in type 2 diabetes mellitus patients. Adv Ther (2009) 0.77
Effect of raloxifene on serum lipids for type 2 diabetic menopausal women with or without statin treatment. Med Princ Pract (2009) 0.77
Discovery and biological characterization of 1-(1H-indol-3-yl)-9H-pyrido[3,4-b]indole as an aryl hydrocarbon receptor activator generated by photoactivation of tryptophan by sunlight. Chem Biol Interact (2011) 0.77
Comparative study between high-dose fluvastatin and low-dose fluvastatin and ezetimibe with regard to the effect on endothelial function in diabetic patients. Endocr J (2011) 0.77
Unliganded RXR acts as an inhibitory factor on troglitazone-induced activation. Life Sci (2004) 0.77
Detection of cysteine S-nitrosylation and tyrosine 3-nitration in kidney proteins. Methods Mol Med (2003) 0.77
A crossover study of rosuvastatin and pitavastatin in patients with type 2 diabetes. Adv Ther (2011) 0.77
PREMATURE VASCULAR SENESCENCE IN METABOLIC SYNDROME: COULD IT BE PREVENTED AND REVERSED BY A SELENORGANIC ANTIOXIDANT AND PEROXYNITRITE SCAVENGER EBSELEN? Drug Discov Today Ther Strateg (2007) 0.77
Expression of thyroid hormone receptor isoforms down-regulated by thyroid hormone in human medulloblastoma cells. Endocr J (2006) 0.76
Excretion of anti-angiogenic proteins in patients with chronic allograft dysfunction. Nephrol Dial Transplant (2012) 0.75
[Effect of angiotensin II type 1 receptor antagonist on oxidative stress markers in type 2 diabetic patients with hypertension]. Nihon Rinsho (2003) 0.75
[Phosphodiesterase-3 inhibitor]. Nihon Rinsho (2010) 0.75
An ACTH-secreting pituitary adenoma within the sphenoid sinus. Intern Med (2010) 0.75
[The diagnosis and treatment of myxedema coma]. Nihon Rinsho (2012) 0.75
A case of myeloma with hypercalcemia caused by high serum concentrations of both parathyroid hormone-related peptide (PTHrP) and macrophage inflammatory protein-1α (MIP-1α). Intern Med (2011) 0.75
[Hypothyroid neuropathy]. Nihon Rinsho (2006) 0.75
[The use and problems of diagnostic guidelines for thyroid diseases]. Nihon Naika Gakkai Zasshi (2010) 0.75
A patient with extreme insulin resistance syndrome treated with pioglitazone. Diabetes Care (2006) 0.75
[Isolated thyroid stimulating hormone deficiency]. Nihon Rinsho (2006) 0.75
Differential modulation of immunostimulant-triggered NO production by endoplasmic reticulum stress inducers in vascular smooth muscle cells. J Cardiovasc Pharmacol (2011) 0.75
The role of C-reactive protein in type 2 diabetes and its macrovascular complications in Chinese. Diabetes Res Clin Pract (2003) 0.75
[Werner's syndrome]. Nihon Rinsho (2006) 0.75